These positive developments are often the result of many years of creative, hard work by amazing teams of researchers.
Here is my top 10 list of these exciting advances.
- 1. First IPSC study in humans by team led by Masayo Takahashi.
- 2. and 3. Major Diabetes advances: ViaCyte starts stem cell-based clinical trial for Diabetes and multiple teams of researchers make human beta cells with some encouraging functions, which may prove very important in the future as a basis for treatment.
- 4. Ocata therapeutics‘ clinical trials for vision impairment continued on track with encouraging published results.
- 5. Stem cell gene editing cures “bubble baby” disease (SCID) in some infants.
- 6. BioTime and its subsidiaries make substantial progress with multiple clinical trial pipelines including Asterias’ push on OPC1 for SCI.
- 7. Human therapeutic cloning of ES cells moves rapidly forward.
- 8. Engineering resistance to HIV in stem cells by UC Davis team in the journal Stem Cells and a team led by Cowan and Rossi at Harvard (reported in Cell Stem Cell paper).
- 9. Young blood reverses aging in mice. Is it at least in part a stem cell-mediated phenomenon?
- 10. CIRM launches CIRM 2.0 with warp speed grant funding mechanism.
Did I miss any in your top 10? Tell us in the comments please.
Note: The author has a small long-term stake in Ocata.